Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies

This publication has 30 references indexed in Scilit:

• PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
  Molecular Cancer Therapeutics, 2011
• Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
  Journal of Clinical Oncology, 2011
• Biology-Driven Phase II Trials: What Is the Optimal Model for Molecular Selection?
  Journal of Clinical Oncology, 2011
• Should liver metastases of breast cancer be biopsied to improve treatment choice?
  Annals of Oncology, 2011
• Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
  Breast Cancer Research, 2010
• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
  Journal of Clinical Oncology, 2010
• Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
  Journal of Clinical Oncology, 2010
• Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
  Annals of Oncology, 2009
• Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
  Clinical Cancer Research, 2008
• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
  Journal of Clinical Oncology, 2007